https://www.selleckchem.com/TGF-beta.html
51-1.79, p less then 0.0001) compared with the matching cohort. Additionally, the rates and odds of 90-day readmission were higher (16.29 vs. 12.66%; OR1.34, p less then 0.0001) and episodes of care costs were significantly greater ($17,105.43 vs. $15,252.34, p less then 0.0001) in patients who had PD. Results demonstrate that PD patients undergoing primary TKA had higher incidences of medical and implant-related complications. They also had increased 90-day readmission rates and costs compared with controls. The findings of this study should b
Like
Comment
Share
